www.hivandhepatitis.com

Back HCV Disease Progression

EASL 2015: Another Study Confirms Detrimental Effects of Delaying Hepatitis C Treatment

Details
Category: HCV Treatment
Published on Thursday, 30 April 2015 00:00
Written by Liz Highleyman
  • Print

Deferring antiviral therapy for hepatitis C until a person progresses to advanced liver disease has clear drawbacks including lower treatment effectiveness and an increased risk of clinical events and death, according to a study of U.S. veterans presented at the European Association for the Study of the Liver (EASL) 50th International Liver Congress last week in Vienna.

alt

Read more:

More Articles...

  1. EASL 2015: Advanced Liver Damage Is Common Among People with Undiagnosed Hepatitis C
  2. CROI 2015: Liver Disease Progression Is Common Among Baby Boomers with Hepatitis C
  3. Liver Cirrhosis Is More Common in U.S. than Previously Believed
  4. 10. Hepatitis C Cures for HIV/HCV Coinfected and Advanced Liver Disease
  5. Cured Hepatitis C Patients May Have Same Life Expectancy as General Population

Subcategories

Copyright © 2025 www.hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com. Joomla! is Free Software released under the GNU General Public License.

Bread and Roses Web DesignWeb Design and Development by Bread and Roses Web Design